Skip to main content

Table 5 Diseases and number of subjects treated with different anti-angiogenic drugs

From: Ophthatome™: an integrated knowledgebase of ophthalmic diseases for translating vision research into the clinic

Anti-VEGF molecules Avastin Lucentis Accentrix Eylea Razumab Anti-VEGF (not specified)
Total number of subjects 3706 942 860 35 310 279
Diseases wise distribution
 Wet AMD 60 17 23 3 7 5
 AMD 102 36 38 8 17 10
 Diabetic retinopathy 1272 256 190 _ 65 75
 Retinal vein occlusion 496 122 119 4 28 26
 Myopic CNMV 4 1 _ _ _ _
 Pathological myopia 5 3 1 _ 1 1
 Neovascular glaucoma 199 37 27 1 10 12
 Retinopathy of prematurity 2 _ _ _ _ _
 Retinal vascular disorder 579 174 65 10 18 21
 Retinal vasculitis 20 3 2 _ _ 1
 Chorioretinopathy 20 7 4 1 1 3
\